Latest News about BLUE
Recent news which mentions BLUE
US Stocks Open Higher, Dow Jumps Over 200 Points
March 29, 2023
From Benzinga
From Benzinga
From Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
From Benzinga
From Benzinga
1 Beaten-Down Stock That Has a Lot to Prove in 2023
February 08, 2023
From Motley Fool
From Benzinga
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
January 22, 2023
From Motley Fool
Tesla, Amazon, bluebird, Netflix, Discover Financial: Why These 5 Stocks Are Drawing Investors' Attention Today
January 18, 2023
From Benzinga
From Benzinga
Why Is Zomedica (ZOM) Stock Up Today?
January 18, 2023
From InvestorPlace
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results
January 18, 2023
From InvestorPlace
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
January 18, 2023
From Motley Fool
Why is Bluebird Bio (BLUE) Stock Down 9% Today?
January 18, 2023
From InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 18, 2023
From Benzinga
From InvestorPlace
2 Stocks That Could Double Your Money in 2023
January 07, 2023
From Motley Fool
Newly Approved Drugs In US Command Over $200,000 On An Average
January 05, 2023
From Benzinga
From Motley Fool
After Doubling in the Past 6 Months, Is This Stock a Buy?
December 24, 2022
From Motley Fool
FDA Allows Bluebird Bio To Resume Sickle Cell Disease Studies In Patients Below 18, With Changed Protocol
December 19, 2022
Tickers
BLUE
From Benzinga
Tickers
BLUE
From InvestorPlace
Magenta Therapeutics Shares Surge After Encouraging Data From Blood Cancer Candidate At ASH Meeting
December 13, 2022
From Benzinga
2 Risky Stocks That Could Soar in 2023
December 06, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.